Search results

• Active

  CoL: CRUK City of London Centre renewal (COLMC)

  Ng, T. (Primary Investigator), Arnold, J. (Co-Investigator), Blower, P. (Co-Investigator), Ciccarelli, F. (Co-Investigator), Dazzi, F. (Co-Investigator), Farzaneh, F. (Co-Investigator), Grigoriadis, A. (Co-Investigator), Hayday, A. (Co-Investigator), Irshad, S. (Co-Investigator), Kong, A. (Co-Investigator), Kordasti, S. (Co-Investigator), Lawrence, T. (Co-Investigator), Mishto, M. (Co-Investigator), Papa, S. (Co-Investigator), Purushotham, A. (Co-Investigator), Quek, L. (Co-Investigator), Ramsay, A. (Co-Investigator), Reis Ferreira, M. (Co-Investigator), Sarker, D. (Co-Investigator), Sinkus, R. (Co-Investigator), Spicer, J. (Co-Investigator) & Witney, T. (Co-Investigator)

  CRUK Cancer Research UK

  1/04/2022 → 31/03/2027

  Project: Research

• MRC-LifeArc: King’s/Royal Free/UCL Gene Therapy Innovation Hub

  Ali, R. (Primary Investigator) & Farzaneh, F. (Co-Investigator)

  MRC Medical Research Council

  1/10/2021 → 30/09/2026

  Project: Research

• Finished

  CNSL: GMP Vector Production - CNSL - University College London

  Farzaneh, F. (Primary Investigator)

  Wellcome Trust

  1/08/2020 → 30/09/2022

  Project: Research

• Production of expanded autologous regulatory T cells to treat patients with refractory aplastic anaemia in a phase I dose study

  Mufti, G. (Primary Investigator), Lombardi, G. (Primary Investigator), Flach, C. (Primary Investigator) & Farzaneh, F. (Primary Investigator)

  Aplastic Anaemia Trust

  18/11/2019 → 31/01/2023

  Project: Research

• AML-2: CD80/IL-2 Immune Gene Therapy for Poor Prognosis Acute Myeloid Leukaemia

  Farzaneh, F. (Primary Investigator) & Mufti, G. (Primary Investigator)

  J P Moulton Charitable Foundation

  1/09/2019 → 31/08/2022

  Project: Research

• Deep Conditioning using CRISPR edited T cells

  Farzaneh, F. (Primary Investigator)

  Wellcome Trust

  1/07/2019 → 30/11/2023

  Project: Research

• Viral vector gene therapy for FTD and ALS: from constructs to clinical trials

  Shaw, C. (Primary Investigator), Lee, Y. (Co-Investigator) & Farzaneh, F. (Co-Investigator)

  UK Dementia Research Institute

  1/01/2019 → 31/12/2022

  Project: Research

• VAPER: A Phase 1 Cancer Vaccine Trial

  Spicer, J. (Primary Investigator) & Farzaneh, F. (Co-Investigator)

  Guy's & St Thomas' Charity

  11/09/2018 → 4/06/2021

  Project: Research

• BCMA as a CAR-T Cell and mechanisms of target escape

  Benjamin, R. (Primary Investigator), Farzaneh, F. (Co-Investigator) & Martins Metelo, A. (Co-Investigator)

  KHP King's Health Partners

  1/06/2018 → 30/09/2018

  Project: Research

• Size selective nanocone biosensor for detecting viral vectors for gene therapy

  Dickson, W. (Primary Investigator) & Farzaneh, F. (Co-Investigator)

  EPSRC Engineering and Physical Sciences Research Council

  1/04/2018 → 31/07/2018

  Project: Research

  • Gene Therapy 100%
  • Virus Vector 100%
  • Biosensor 100%

• Vaccination-mediated immunity against tumour recurrence in oesophago-gastric adenocarcinoma

  Lagergren, J. (Primary Investigator) & Farzaneh, F. (Primary Investigator)

  Guy's & St Thomas' Charity

  1/01/2018 → 31/12/2018

  Project: Research

• Organoid cell therapy for paediatric acute liver failure: Bridging bench to bedside strategies

  Dhawan, A. (Co-Investigator) & Farzaneh, F. (Co-Investigator)

  1/05/2017 → 30/04/2022

  Project: Research

• KHP Centre Award - Non-Clinical Training Award

  Parker, P. (Primary Investigator), Spicer, J. (Primary Investigator), Ciccarelli, F. (Co-Investigator), Dazzi, F. (Co-Investigator), Farzaneh, F. (Co-Investigator), Hayday, A. (Co-Investigator), Maher, J. (Co-Investigator), Ng, T. (Co-Investigator), Papa, S. (Co-Investigator), Purushotham, A. (Co-Investigator) & Sarker, D. (Co-Investigator)

  CRUK Cancer Research UK

  1/04/2017 → 31/03/2025

  Project: Research

  • Awards 100%
  • Training 80%
  • Award 20%

• Adaptation of former HeLa based Cancer-Killing Assay of human leukocytes to be based on Pancreatic Cancer cells in order to increase the specificity of the assay in Pancreatic Cancer

  Farzaneh, F. (Primary Investigator)

  GLA Greater London Authority

  1/04/2017 → 31/03/2019

  Project: Research

• Pre-Clinical development of a Stem Cell based Gene Therapy protocol and clinical proof of principle for Duchenne Muscular Dystrophy

  Farzaneh, F. (Primary Investigator)

  Wellcome Trust

  1/06/2016 → 31/05/2019

  Project: Research

• Large scale lentiviral vector production

  Farzaneh, F. (Primary Investigator) & Chan, L. (Co-Investigator)

  BBSRC Biotechnology and Biological Sciences Research Council

  1/11/2015 → 31/10/2018

  Project: Research

• Next generation CAR19 studies

  Farzaneh, F. (Primary Investigator)

  NIHR National Institute For Health & Care Research

  1/11/2015 → 30/04/2019

  Project: Research

• In Vivo Generation of Optimal Tumour Antigen-specific Anticancer Immune Responses, by Vaccination with Human Telomerase Reverse Transcriptase (hTERT) Peptides, in Combination with Specific Adjuvants and Elimination of Immunosuppressive Regulatory Cells, in Patients with Advanced Cancer. Phase 1 Study (VAPER)

  Spicer, J. (Primary Investigator) & Farzaneh, F. (Co-Investigator)

  Candles

  1/07/2015 → 31/12/2019

  Project: Research

• Next Generation Studies

  Farzaneh, F. (Primary Investigator)

  1/04/2015 → 31/03/2018

  Project: Research

• Pre-emptive immune therapy to prevent relapse of myeloid malignancies

  Barber, L. (Primary Investigator), Farzaneh, F. (Primary Investigator), Lombardi, G. (Co-Investigator), Maher, J. (Co-Investigator), Mufti, G. (Co-Investigator) & So, E. (Co-Investigator)

  Blood Cancer UK

  1/08/2013 → 31/12/2017

  Project: Research

• An immunisation strategy to prevent hepatocellular carcinoma

  Farzaneh, F. (Primary Investigator), Harrison, P. (Co-Investigator), Noble, A. (Co-Investigator) & Noelle, R. (Co-Investigator)

  1/04/2013 → 31/03/2015

  Project: Research

• Development of enhanced gene specific technology for the isolation of proteins binding at a single locus in vivo

  Farzaneh, F. (Primary Investigator) & Ford, K. (Primary Investigator)

  BBSRC Biotechnology and Biological Sciences Research Council

  1/03/2013 → 26/08/2014

  Project: Research

• Novel non-coding RNAs conrolling cell fate during leukaemia development and therapy

  Farzaneh, F. (Primary Investigator)

  1/01/2013 → 1/01/2015

  Project: Research

• NIHR Clinical Research Facility infrastructure

  McGregor, A. (Primary Investigator), Farzaneh, F. (Co-Investigator) & Williams, S. (Co-Investigator)

  NIHR National Institute For Health & Care Research

  1/09/2012 → 31/03/2017

  Project: Research

• Development of a Vaccine for the Treatment of hepatitis B v infection

  Harrison, P. (Primary Investigator), Farzaneh, F. (Co-Investigator) & Noble, A. (Co-Investigator)

  1/06/2012 → 31/05/2013

  Project: Research

• An immunisation strategy to prevent hepatocellular carcinoma

  Harrison, P. (Primary Investigator), Farzaneh, F. (Co-Investigator) & Noble, A. (Co-Investigator)

  1/05/2012 → 30/04/2015

  Project: Research

• Experimental Cancer Medicine Centre

  Purushotham, A. (Primary Investigator), Spicer, J. (Primary Investigator), Farzaneh, F. (Co-Investigator), Hayday, A. (Co-Investigator), Holmberg, L. (Co-Investigator), Karagiannis, S. (Co-Investigator), Nestle, F. (Co-Investigator), Ng, T. (Co-Investigator), Parker, P. (Co-Investigator), Pinder, S. (Co-Investigator) & Sarker, D. (Co-Investigator)

  CRUK Cancer Research UK

  1/04/2012 → 31/03/2017

  Project: Research

• 'T4 immunotherapy' of head and neck cancer using genetically engineered T-cells

  Maher, J. (Primary Investigator), Farzaneh, F. (Co-Investigator) & Spicer, J. (Co-Investigator)

  J P Moulton Charitable Foundation

  1/02/2012 → 30/04/2021

  Project: Research

• A Phase-I study of lentivirus transduced acute myeloid leukaemic cells expressing B7.1 (CD80) and IL-2 for the potential induction of graft versus leukaemia (GVL) effect in poor prognosis AML

  Farzaneh, F. (Primary Investigator)

  1/02/2012 → 31/01/2015

  Project: Research

• Innate Immune Responses In Hepatitis Delta Virus Infection

  Harrison, P. (Primary Investigator), Farzaneh, F. (Co-Investigator) & academic, A. (Co-Investigator)

  1/10/2011 → 30/09/2014

  Project: Research

• Development of a Theraputic Vaccine for the Treatment of Hepatitis B virus Infection

  Harrison, P. (Primary Investigator), Farzaneh, F. (Co-Investigator) & Noble, A. (Co-Investigator)

  1/10/2011 → 30/09/2013

  Project: Research

• Abrogating CD8 T cell tolerance to tumour-associated antigens

  Noble, A. (Primary Investigator) & Farzaneh, F. (Co-Investigator)

  1/05/2011 → 30/04/2014

  Project: Research

• Development of a therapeutic HBV vaccine

  Harrison, P. (Primary Investigator), Noble, A. (Primary Investigator) & Farzaneh, F. (Co-Investigator)

  1/03/2011 → 28/02/2015

  Project: Research

• Immune dysregulation in bone marrow failure syndromes: implications for pathogenesis and clonal evolution.

  Mufti, G. (Primary Investigator), Farzaneh, F. (Co-Investigator), Thomas, S. (Co-Investigator) & Kordasti, S. (Co-Investigator)

  Blood Cancer UK

  1/10/2010 → 28/02/2021

  Project: Research

• Gene therapy clinical trial

  Farzaneh, F. (Primary Investigator) & Mufti, G. (Primary Investigator)

  Leukaemia UK

  1/03/2010 → 28/02/2013

  Project: Research

• Immune biology and immune therapy of acute myeloid leukaemia

  Farzaneh, F. (Primary Investigator) & Mufti, G. (Primary Investigator)

  1/03/2010 → 28/02/2013

  Project: Research

• Two dimensional ultra high-pressure high resolution liquid chromatography and mass spectrometry for multi-user advanced bioanalysis.

  Cowan, D. (Primary Investigator), Bansal, S. (Co-Investigator), Farzaneh, F. (Co-Investigator), Hider, R. (Co-Investigator), Hogstrand, C. (Co-Investigator), Parkin, M. (Co-Investigator) & Thomas, S. (Co-Investigator)

  1/01/2010 → 31/12/2014

  Project: Research

• Development of a therapeutic HBV vaccine

  Farzaneh, F. (Primary Investigator), Harrison, P. (Co-Investigator), Hui, K. M. (Co-Investigator), Noble, A. (Co-Investigator) & Ooi, L. L. (Co-Investigator)

  1/01/2010 → 31/12/2011

  Project: Research

• A comprehensive programme in Leukaemia Immune Therapy

  Farzaneh, F. (Primary Investigator) & Mufti, G. (Primary Investigator)

  1/01/2010 → 31/12/2012

  Project: Research

• Two dimensional ultra high-pressure high resolution liquid chromatography and mass spectrometry for multi-user advanced bioanalysis

  Cowan, D. (Primary Investigator), Bansal, S. (Co-Investigator), Farzaneh, F. (Co-Investigator), Hider, R. (Co-Investigator), Hogstrand, C. (Co-Investigator), Parkin, M. (Co-Investigator) & Thomas, S. (Co-Investigator)

  1/01/2010 → 31/12/2014

  Project: Research

• Development of a therapeutic HBC vaccine

  Farzaneh, F. (Primary Investigator) & Thomas, S. (Primary Investigator)

  1/01/2010 → 31/12/2012

  Project: Research

• Immune therapy of Leukaemia and multiple myeloma

  Farzaneh, F. (Primary Investigator) & Schey, S. (Co-Investigator)

  Cancer Vaccines Institute

  1/10/2009 → 30/09/2011

  Project: Research

• Immunotherapy of ovarian cancer using t-cells engrafted with chimeric antigen and cytokine receptors

  Burchell, J. (Primary Investigator), Maher, J. (Primary Investigator), Farzaneh, F. (Co-Investigator) & Mullen, G. (Co-Investigator)

  1/09/2009 → 31/08/2012

  Project: Research

• Adoptive immunotherapy of metastatic prostate cancer using PSMA re-targeted T-lymphocytes

  Antoniou, M. (Primary Investigator), Maher, J. (Primary Investigator), Chowdhury, P. (Co-Investigator), Farzaneh, F. (Co-Investigator), Mullen, G. (Co-Investigator) & Papa, S. (Co-Investigator)

  1/05/2009 → 30/04/2012

  Project: Research

• Identification of the tumour-specific apoptin kinases

  Tavassoli, M. (Primary Investigator) & Farzaneh, F. (Co-Investigator)

  CRUK Cancer Research UK

  1/10/2008 → 30/09/2012

  Project: Research

• CRUK Doctoral Training Fellowship

  Farzaneh, F. (Primary Investigator) & Tavassoli, M. (Primary Investigator)

  1/10/2008 → 30/09/2012

  Project: Research

• Formulation of MAS-1 adjuvant with innate immune activators to induce CD8+ T cell-mediated immunity by tumour-specific antigens for the immunotherapy of cancer

  Noble, A. (Primary Investigator) & Farzaneh, F. (Co-Investigator)

  1/04/2008 → 31/03/2010

  Project: Research

• NIHR Biomedical Research Centre

  Afzali, B. (Primary Investigator), Antoniou, M. (Primary Investigator), Barker, J. (Primary Investigator), Barratt, B. (Primary Investigator), Beighton, D. (Primary Investigator), Bevan, S. (Primary Investigator), Blower, P. (Primary Investigator), Burchell, J. (Primary Investigator), Cason, J. (Primary Investigator), Chappell, L. (Primary Investigator), Cope, A. (Primary Investigator), Corrigan, C. (Primary Investigator), Cunninghame Graham, D. (Primary Investigator), Dontu, G. (Primary Investigator), Edgeworth, J. (Primary Investigator), Farzaneh, F. (Primary Investigator), Gee, T. (Primary Investigator), Gould, H. (Primary Investigator), Green, P. (Primary Investigator), Greenough, A. (Primary Investigator), Grigoriadis, A. (Primary Investigator), Hayday, A. (Primary Investigator), Higginson, I. (Primary Investigator), Kalra, L. (Primary Investigator), Karagiannis, S. (Primary Investigator), Kelly, F. (Primary Investigator), Kemper, C. (Primary Investigator), Lau-Walker, M. (Primary Investigator), Lavender, P. (Primary Investigator), Lee, T. (Primary Investigator), Lempp, H. (Primary Investigator), Lewis, C. (Primary Investigator), Lombardi, G. (Primary Investigator), Lord, G. (Primary Investigator), Marber, M. (Primary Investigator), Mason, J. (Primary Investigator), Mathew, C. (Primary Investigator), McGrath, J. (Primary Investigator), Metcalfe, A. (Primary Investigator), Molokhia, M. (Primary Investigator), Mullen, G. (Primary Investigator), Nagel, E. (Primary Investigator), Neil, S. (Primary Investigator), Nestle, F. (Primary Investigator), Oakey, R. (Primary Investigator), Parker, P. (Primary Investigator), Peakman, M. (Primary Investigator), Perera, D. (Primary Investigator), Purushotham, A. (Primary Investigator), Rasekh Ahmadi, K. (Primary Investigator), Rashid, T. (Primary Investigator), Razavi, R. (Primary Investigator), Ridley, A. (Primary Investigator), Robson, M. (Primary Investigator), Sacks, S. (Primary Investigator), Sanchez Fueyo, A. (Primary Investigator), Santis, G. (Primary Investigator), Sanz Moreno, V. (Primary Investigator), Sawyer, E. (Primary Investigator), Schaeffter, T. (Primary Investigator), Shah, A. (Primary Investigator), Sharpe, P. (Primary Investigator), Simpson, M. (Primary Investigator), Smith, R. (Primary Investigator), Sorinola, I. (Primary Investigator), Spector, T. (Primary Investigator), Spicer, J. (Primary Investigator), Taams, L. (Primary Investigator), Tavassoli, M. (Primary Investigator), Taylor, D. (Primary Investigator), Tree, T. (Primary Investigator), Trembath, R. (Primary Investigator), Tribe, R. (Primary Investigator), Tutt, A. (Primary Investigator), Waltham, M. (Primary Investigator), Watt, F. (Primary Investigator), Webb, A. (Primary Investigator), Wells, C. (Primary Investigator), Whelan, K. (Primary Investigator), Whitaker, J. (Primary Investigator), Whittlesea, C. (Primary Investigator), Williamson, C. (Primary Investigator), Wolfe, C. (Primary Investigator), Yu, V. (Primary Investigator), academic, A. (Primary Investigator), Hughes, S. (Co-Investigator), Montana, G. (Co-Investigator), Rhode, K. (Co-Investigator), Schnabel, J. (Co-Investigator) & Tziotzios, C. (Co-Investigator)

  NIHR National Institute For Health & Care Research, DHSC Department of Health and Social Care

  1/04/2007 → 31/03/2017

  Project: Research

  • T-Helper Cell 100%
  • Inflammatory Arthritis 66%
  • Interleukin 17 66%
  • T Cell 44%
  • Interleukin 10 41%

• BRIC: packaging cell lines for inherently manufacturable human vectors

  Farzaneh, F. (Primary Investigator) & Darling, D. (Co-Investigator)

  BBSRC Biotechnology and Biological Sciences Research Council

  1/10/2006 → 31/03/2010

  Project: Research

• King's Experimental Cancer Centre

  Parker, P. (Primary Investigator), Purushotham, A. (Primary Investigator), Blower, P. (Co-Investigator), Burchell, J. (Co-Investigator), Diebold, S. (Co-Investigator), Ellis, P. (Co-Investigator), Farzaneh, F. (Co-Investigator), Gillett, C. (Co-Investigator), Grimwade, D. (Co-Investigator), Harries, M. (Co-Investigator), Hayday, A. (Co-Investigator), Lewis, C. (Co-Investigator), Marsden, P. (Co-Investigator), Mufti, G. (Co-Investigator), Møller, H. (Co-Investigator), Nestle, F. (Co-Investigator), Ng, T. (Co-Investigator), O'Doherty, M. (Co-Investigator), Sawyer, E. (Co-Investigator), Schey, S. (Co-Investigator), Solomon, E. (Co-Investigator), Spencer, J. (Co-Investigator), Taylor-Papadimitriou, J. (Co-Investigator), Tutt, A. (Co-Investigator) & Whittaker, S. (Co-Investigator)

  CRUK Cancer Research UK

  1/08/2006 → 31/03/2012

  Project: Research